Sentinel / Breast International Group / Erb / Giuliano AE / ED France / /
Continent
Europe / /
Country
Switzerland / France / United Kingdom / Italy / Austria / United States / Czech Republic / /
Event
FDA Phase / /
Facility
University of Geneva / European Institute of Oncology / European Commission Institute / With headquarters / Medical University of Vienna / Institute of Social / /
IndustryTerm
digital technology / web hub / insurance / equal quality services / food / web-based ww / treatment of breast cancer / online format / treatment for this type of breast cancer / prevention of breast cancer / prevention of secondary breast cancer / cancer services / low-fat dairy products / cancer treatment / Therapy of Early Breast Cancer / breast cancer care / pharmaceutical / breast cancer treatment / energy-dense food / web-based format / energy balance / web-based platform / food safety / classification systems / breast cancer services / /
MedicalCondition
turn increase cancer / basal-like disease / abdominal obesity / adenoid cystic carcinomas / oestrogen-receptor-negative breast cancer / non-invasive carcinoma / Action Against Cancer / early breast cancer / distant metastasis / metastatic disease / melanoma / HER2-positive disease / postmenopausal breast cancer / breast cancer / asymptomatic breast cancer / nodepositive disease / negative breast cancer / early-stage breast cancer / visceral metastasis / Cancer / late metastasis / oestrogen-receptor-responsive tumours / European Code Against Cancer / New In Gene Assays For Prognostic Signatures Breast cancer / oestrogenreceptor-negative breast cancer / high-quality breast cancer / chronic disease / diseases / fatty tissue / tumours / lower breast cancer / triple-negative disease / invasive cancer / metastasis / local disease / quality breast cancer / J Cancer / inflammatory markers / metastatic breast cancer / obesity / HER2/neu-negative metastatic breast cancer / triple-negative breast cancer / Czech cancer / insulin resistance / breast cancers / evidence-based cancer / common cancer / triple-negative breast cancers / particularly oestrogen-receptor-positive breast cancer / rare disease / tumour / secondary breast cancer / premenopausal breast cancer / post-menopausal breast cancer / inflammation / tumour in her breast / /
MedicalTreatment
Endocrine therapy / plastic surgery / surgical treatment / surgery / chemotherapy / neoadjuvant treatment / /
Organization
World Health Organization / University of Geneva / European Institute of Oncology / Institute for Health and Consumer Protection / European Parliament / Joint Research Centre / Institute of Social and Preventive Medicine / European Commission / European Commission’s Joint Research Centre / European Commission Institute for Health and Consumer Protection / Association of Czech Breast Radiologists / European Union / Ministry of Health / Prague Breast Unit / Department of Surgery in Vienna / European Medicines Agency / Breast Cancer Research Foundation / US Food and Drug Administration / Ministry of Health’s Committee for Breast Cancer Screening / University of Vienna / Public Health Policy Support Unit / Innovative Therapies Division / International Agency for Research / /
Person
Dorothy Goddard / Elisabeth Marnier / Susan Knox / Ene Tomberg / Ismael G et al. Lancet / Arch Intern Med / Marta Kostrová / Ann Oncol / Sema Erdem Axillary / Krzysztof Maruszewski / Bettina Borisch / Antonella Moreo Take / Peter Dubsky / Nicole Zernik / Maricel Marin-Kuan / Elizabeth Bergsten Nordström / Giuseppe Curigliano / Isabelle Romieu / Miroslava Skovajsová / /
Position
custodian / National Clinical Advisor / Executive Director / President / gynaecologist / pilot quality assurance scheme / Head / Professor / pathologist / Representative / Associate Professor / general practitioner / Directorate General / speaker / Consultant / Professor of Surgery / Director / Chair / Chair of the Early Drug Development / /
Product
exemestane / vitamin D / letrozole / EU / USA / /
ProgrammingLanguage
EC / /
ProvinceOrState
AURORA / /
Technology
chemotherapy / ultrasound / DNA sequencing / Drug Development / /
11 Highlights of the th EUROPA DONNA